Posts by Suma Babu, MBBS, MPH
-
High-Dose Tamoxifen "Wins" Selection Trial in ALS
In a selection trial—a randomized trial in which multiple experimental treatments were compared simultaneously—tamoxifen 80 mg/day was numerically superior to tamoxifen 40 mg/day and creatine 30 g/day on the primary endpoint of functional decline.
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.